Key to cancer drug use pinpointed
Date: 18.12.2007
Scientists have discovered why a treatment for ovarian **cancer** only works in half of the patients who have it
Paclitaxel shrinks ovarian tumours - but Cambridge University researchers found that patients lacking a specific type of protein tend to be immune.
Cancer Research UK, who funded the survey along with the Medical Research Council, said it will help ensure **drugs** are given to those likely to benefit.
Whole article on "BBC NEWS":[ http://news.bbc.co.uk/2/hi/health/7136632.stm]
